[Image courtesy of Kayi Lawson / WHO]
HealthNews

Africa CDC-led Study Sounds Alarm on Spreading Antimicrobial Drug Resistance

A newly published joint study of regional partners finds increasing levels of Antimicrobial drug resistance across African countries, making common infections harder to treat and more expensive to manage.

The results of the Africa Centres for Disease Control and Prevention or Africa CDC – led research was released on Wednesday July 23, 2025.

The African Union public health specialized agency says the study – known as Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) – is the “largest of its kind ever conducted in Africa.”

Researchers reviewed more than 187,000 test results from 205 laboratories collected between 2016 and 2019 from Burkina Faso, Eswatini, Ethiopia, Ghana, Kenya, Malawi, Mali, Nigeria, Senegal, Sierra Leone, Tanzania, Uganda, Zambia, and Zimbabwe.

The findings highlight the growing spread of drug resistance across the continent despite serious gaps in lab testing and data.

Drug resistance occurs when bacteria change in ways that make antibiotics – medicines used to treat infections – less effective. “This means that common infections become harder to treat, more expensive to manage, and more likely to spread,” the Africa CDC says announcing the results.

Varying Resistance Levels

The researchers examined bacteria that commonly cause serious illness, such as E. coli, Staphylococcus aureus, and Klebsiella pneumoniae.

According to them, one of the most concerning findings was that resistance to a powerful group of antibiotics, known as third-generation cephalosporins, was especially high in Ghana and Malawi.

More than half of the Staphylococcus aureus samples from six countries were resistant to methicillin – an antibiotic commonly used in hospitals. In Nigeria and Ghana, resistance levels exceeded the 70% mark.

The research also shows that some groups are more likely to have drug-resistant infections. People over the age of 65 were 28% more likely to have resistant infections than younger adults.

Patients already admitted to hospitals had a 24% higher risk, likely due to increased exposure to antibiotics. Previous use of antibiotics was also linked to higher resistance.

“Serious” Testing, Data Gaps

The study also shows serious gaps in need to strengthen lab testing, data systems, and health planning to tackle hard-to-treat infections.

Fewer than 2% of health facilities were equipped to test for bacterial infections, and only 12% of drug resistance records were linked to patient information.

“Without this kind of data, it is more difficult for health officials to understand how and why resistance is spreading,” Africa CDC says.

The gap also extends to the quality of data collected which also varies among the countries. Senegal, for instance, had “the strongest systems,” while Sierra Leone struggled with data collection. And also many laboratories still use handwritten records, and most lack reliable digital systems, the study claims.

“We must act now”

The study suggest to governments “to make drug resistance a national priority” by investing in better laboratories, routine testing, and stronger digital systems.

Beyond that, experts also want to see collaborative efforts to deal with the Antimicrobial resistance. “AMR remains a complex problem for African countries, leaving them with the million-dollar question: ‘Where do we start from?’,” says Dr Yewande Alimi, a One Health Unit Lead at the Africa CDC.

“This study brings to light groundbreaking AMR data for African countries. We must act now – and together – to address AMR,” Dr Alimi underscores.

The African Society for Laboratory Medicine (ASLM), and One Health Trust were also among the lead regional partners on the study conducted with support from the UK’s Fleming Fund and the U.S. Centres for Disease Control (CDC).